American Cancer Society Postdoctoral Fellowship 2026–2027: Up to Three Years of Progressive $66,000–$70,000 Stipends for Early-Career Cancer Researchers

American Cancer Society Postdoctoral Fellowship 2026–2027: Up to Three Years of Progressive $66,000–$70,000 Stipends for Early-Career Cancer Researchers

The years right after a doctorate are when many cancer researchers do their most inventive work and, paradoxically, when their funding is most precarious. The American Cancer Society (ACS) Postdoctoral Fellowship exists to steady that stretch. It gives new investigators the salary support and protected time to build a research record strong enough to launch an independent career, without having to chase piecemeal funding or abandon a promising line of inquiry for lack of a stipend. For the 2026–2027 cycle, the fellowship pays a progressive stipend of $66,000, $68,000, and $70,000 across up to three years, plus a $4,000 annual allowance for costs like health insurance and conferences and an extra $1,500 in the final year.

This guide is built from the American Cancer Society’s official program page rather than a reposted summary. It lays out exactly what the fellowship covers, who qualifies, how the two annual deadlines work, what a competitive application looks like, and where applicants most often stumble. If you are a postdoctoral researcher within three years of your doctorate and working on cancer, this is one of the more accessible and respected fellowships available in the United States, and it rewards candidates who plan ahead.

Key Details at a Glance

Read this table as a starting map. The two fixed deadlines each year make the timeline predictable, but the real work — a sharp research proposal, a committed mentor, and a training plan that reviewers find convincing — has to be underway well before you open the portal.

What the Fellowship Offers

The core benefit is salary. ACS pays a progressive stipend that rises each year — $66,000, then $68,000, then $70,000 — so support keeps pace as you gain experience and take on more responsibility in the lab. Because the stipend is a defined salary rather than a variable line item, it gives both you and your host institution a stable number to plan around for the full term.

On top of the stipend, fellows receive a $4,000 allowance each year to help cover costs the salary alone does not, such as health insurance premiums and attendance at scientific conferences where early-career researchers present their work and meet potential collaborators and future employers. In the final year, an additional $1,500 is added to that allowance, recognizing that the last stretch of a fellowship is often when researchers travel most to present results and interview for independent positions.

The award runs for up to three years and cannot be renewed, so applicants request either a two- or three-year term up front based on the scope of their training plan. The fellowship also protects family time: fellows may take a minimum of four weeks and up to twelve weeks of paid parental leave per year, with the grant term extended accordingly and the stipend continuing throughout. That provision matters for a population of researchers who are frequently starting families during exactly these years.

Beyond the money, an American Cancer Society fellowship carries real weight on a CV. ACS is one of the largest non-governmental funders of cancer research in the United States, and its peer-reviewed awards signal to search committees, department chairs, and future funders that an established, rigorous review process judged your project and your potential worth backing. For a postdoc trying to demonstrate independence and momentum, that external validation is part of the value.

Who Should Apply

This fellowship is designed for postdoctoral researchers early in their training who intend to build independent careers in cancer research. If you have recently completed a doctorate, you hold a postdoctoral (non-faculty) position, and your work advances the understanding, prevention, detection, or treatment of cancer, you are the intended audience.

The program supports a broad span of disciplines. ACS reviews applications across categories that include cell biology, biochemistry, immunology, and clinical sciences, among others, so the fellowship is not confined to a single kind of cancer or a single methodology. Basic laboratory scientists, translational researchers, and those working closer to the clinic all have a place in the pool, provided the work is fundamentally about cancer.

The strongest candidates share a few traits: a clearly defined research question with a credible plan to answer it, a mentor and environment that can genuinely support the proposed training, and evidence that the fellowship period will broaden their skills rather than simply continue what they already do. Because the program’s stated purpose is to position new investigators for independence, reviewers are looking for a trajectory — a sense that this two or three years is a deliberate step toward running your own lab, not a holding pattern.

Eligibility in Detail

The eligibility rules are specific, and getting them right before you invest time in a proposal is essential. Based on the official program page:

• You must hold a terminal doctoral degree — such as a PhD, MD, DO, DVM, or an equivalent — earned no more than three years before the application deadline. Time spent in clinical training does not count against that three-year window, which is important for physician-scientists whose residencies and fellowships would otherwise consume the eligibility clock.
• You must hold a postdoctoral position. Faculty appointments disqualify a candidate; this is a training award, not a grant for established independent investigators.
• Your host must be a U.S. academic institution or an eligible non-profit organization.
• You must be a U.S. citizen or hold appropriate visa or lawful immigration status that allows you to conduct the proposed research in the United States.
• You may submit only one application per cycle.

If you are unsure whether your degree date, clinical training, or immigration status places you inside the eligibility window, the American Cancer Society asks that you contact [email protected] at least six weeks before the deadline. Do not leave this to the final days — an eligibility question answered too late can cost you an entire cycle.

Deadlines and Timeline

The American Cancer Society runs two review cycles a year, with fellowship applications due on June 1 and December 1. When either date falls on a weekend or holiday, applications are accepted on the following business day. For the 2026–2027 planning horizon, the next fixed deadline is December 1, 2026, with the June 1 date recurring the following year.

Two deadlines a year is genuinely useful. If you miss one or are not quite ready, the next window is only six months away, and you can use that time to strengthen preliminary data, refine the proposal, or secure a stronger letter from your mentor. It also lets you time your application to your own readiness rather than to a single annual scramble.

There is no letter of intent, so the full application is what reviewers see. That means the entire package — research plan, training plan, mentor and institutional support, and your record — needs to be complete and polished by the deadline. Build your timeline backward from June 1 or December 1: reserve the final two weeks for institutional sign-off and ProposalCentral submission mechanics, and aim to have a near-final draft circulating among your mentor and colleagues several weeks before that.

The Application Process and Required Materials

Applications are submitted through ProposalCentral, the online grants platform ACS uses. Register early; creating and verifying accounts, linking your institution, and coordinating with your institution’s grants or sponsored-programs office always takes longer than expected, and your submission must typically clear institutional approval before it reaches ACS.

While the official page does not enumerate every component, applications of this kind generally require a detailed research proposal, a training plan describing how the fellowship will broaden your skills, biosketches or CVs for you and your mentor, a statement of mentor and institutional commitment, and a budget consistent with the defined stipend and allowance. Peer reviewers weigh, among other things, how well the fellowship will broaden the applicant’s research training — so the training plan is not a formality. Treat it as a core piece of the application that shows a clear arc from your current abilities to the independent scientist you intend to become.

Because reviewers assess both the science and the training environment, secure your mentor’s genuine engagement early. A strong mentor letter that speaks specifically to your potential, the resources available, and the mentorship structure carries far more weight than a generic endorsement. Confirm well ahead of the deadline that your mentor has the time and materials to write it well.

Preparation Strategy and Reviewer Expectations

The applications that succeed tend to do three things well. First, they pose a focused, important cancer research question and lay out a feasible plan to address it, with enough preliminary evidence or logical grounding to make success plausible. Reviewers are wary of proposals that are ambitious but vague; specificity signals that you have thought the project through.

Second, they make the training case explicitly. This is a fellowship for building toward independence, so connect the proposed work to concrete skills, techniques, or collaborations you will gain, and explain how the host lab and institution uniquely enable that growth. A proposal that reads as “more of the same” is weaker than one that shows deliberate expansion into new methods or questions.

Third, they present a credible environment. The mentor’s track record, the resources of the lab and institution, and a clear plan for supervision and career development all reassure reviewers that the investment will pay off. Where you can, quantify the support — equipment, core facilities, collaborators — rather than asserting it in the abstract.

Finally, write for a knowledgeable but not hyper-specialized reader. Panels cover a range of cancer disciplines, so a proposal that explains its significance clearly to an immunologist and a cell biologist alike will fare better than one buried in jargon.

Common Mistakes to Avoid

• Misjudging the eligibility window. The three-years-since-doctorate rule, and the exclusion of clinical training time from that count, trips up many otherwise strong candidates. Confirm your status with [email protected] at least six weeks out.
• Underinvesting in the training plan. Because reviewers explicitly weigh how the fellowship broadens your training, a thin or generic training plan is a common and avoidable weakness.
• Leaving institutional approval to the last minute. ProposalCentral submissions usually route through your institution’s grants office. Start that process early so a signature bottleneck does not cost you the deadline.
• Requesting the wrong term length. Decide deliberately between a two- and three-year request based on the real scope of your project and training goals, rather than defaulting to the maximum.
• Treating the fellowship as a standalone plan. A competitive stipend supports you, but pairing it with a clear path toward independence — and, eventually, your own funding — is what reviewers want to see.

Frequently Asked Questions

How much does the fellowship pay? A progressive stipend of $66,000 in year one, $68,000 in year two, and $70,000 in year three, plus a $4,000 annual allowance for costs such as health insurance and conferences, with an additional $1,500 added in the final year.

How long is the award? Up to three years. Applicants request either a two- or three-year term, and the fellowship cannot be renewed.

When are applications due? June 1 and December 1 each year. If the date falls on a weekend or holiday, applications are accepted the following business day.

Is there a letter of intent? No. The full application is submitted directly through ProposalCentral.

Do I have to be a U.S. citizen? Not necessarily. You must be a U.S. citizen or hold appropriate visa or lawful immigration status to carry out the research at a U.S. institution.

Does time in clinical training count against the three-year eligibility limit? No. Clinical training time is excluded when calculating whether your doctoral degree was earned within the past three years.

Can I take parental leave? Yes. Fellows may take a minimum of four weeks and up to twelve weeks of paid parental leave per year, with the grant term extended and stipend continuing during leave.

Official Links and Next Steps

Start at the American Cancer Society’s official program page for the Postdoctoral Fellowship to confirm the current stipend figures, eligibility rules, deadlines, and application instructions, then move to ProposalCentral to begin your application: cancer.org — Postdoctoral Fellowships. If you have any doubt about whether you meet the eligibility criteria, email [email protected] at least six weeks before the deadline.

Practical next steps: verify your eligibility window, confirm your mentor’s commitment and their willingness to write a strong, specific letter, register on ProposalCentral early, and build your timeline backward from June 1 or December 1 so that institutional sign-off and submission mechanics are handled with room to spare. With two cycles a year and a clear focus on training toward independence, the American Cancer Society Postdoctoral Fellowship rewards applicants who prepare deliberately and make an honest, well-evidenced case for where their careers are headed.